Latigo Biotherapeutics, Inc. · NASDAQ:LTGO

Seidenberg Beth C converted 12,695,305 Latigo Biotherapeutics, Inc. shares (Form 4)

Traded Aug 10, 2026 · Filed Aug 10, 2026

On Aug 10, 2026, Seidenberg Beth C (Director, 10% owner) converted 12,695,305 Latigo Biotherapeutics, Inc. shares, leaving 2,094,813 shares. Filed Aug 10, 2026 (Form 4).

Converted
12,695,305 shares
Holding after
2,094,813 shares (held indirectly)
Trading plan
No
Role
Director, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 10, 2026Common StockConversion938,9791,368,532Indirect
Aug 10, 2026Common StockConversion3,547,8424,916,374Indirect
Aug 10, 2026Common StockConversion1,027,6355,944,009Indirect
Aug 10, 2026Common StockConversion3,464,0723,510,927Indirect
Aug 10, 2026Common StockConversion1,484,4014,995,328Indirect
Aug 10, 2026Common StockConversion165,5195,160,847Indirect
Aug 10, 2026Common StockConversion2,066,8572,094,813Indirect

Source

View original at SEC

Related